Trial intelligence / Profile preview

EC-MPS for Steroid Withdrawal in Maintenance Renal Transplant

NCT00239057Phase 3Completed

Sponsor
Novartis
Start
May 2002
Primary completion
Jan 2005
Modality
Small Molecules
01

Overview

A Phase 3 trial of mycophenolate sodium in kidney transplant, sponsored by Novartis. Started May 2002; status: completed.

02

Drugs

mycophenolate sodium
03

Conditions

kidney transplant

Beyond the preview

Go deeper on NCT00239057.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00239057.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call